Evidence map›Paper›PMID 39695368›Full record

ArticleBMC genomics2024

DeepMoIC: multi-omics data integration via deep graph convolutional networks for cancer subtype classification.

Jiecheng Wu, Zhaoliang Chen, Shunxin Xiao, Genggeng Liu, Wenjie Wu, Shiping Wang

Abstract read
In one paragraph

Article in BMC genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiecheng WuCollege of Computer and Data Science, Fuzhou University, Fuzhou, 350108, China.
Zhaoliang ChenDepartment of Computer Science, Hong Kong Baptist University, Hong Kong, SAR, China.
Shunxin XiaoSchool of Computer and Information Engineering, Xiamen University of Technology, Xiamen, 361024, China.
Genggeng LiuCollege of Computer and Data Science, Fuzhou University, Fuzhou, 350108, China.
Wenjie WuDepartment of Ophthalmology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, 350001, China.
Shiping WangCollege of Computer and Data Science, Fuzhou University, Fuzhou, 350108, China. shipingwangphd@163.com.

Funding

National Key Research and Development Plan of China 2021YFB3600503National Natural Science Foundation of China U21A20472
6 · The paper itself

Abstract

backgroundAchieving precise cancer subtype classification is imperative for effective prognosis and treatment. Multi-omics studies, encompassing diverse data modalities, have emerged as powerful tools for unraveling the complexities of cancer. However, owing to the intricacies of biological data, multi-omics datasets generally show variations in data types, scales, and distributions. These intractable problems lead to challenges in exploring intact representations from heterogeneous data, which often result in inaccuracies in multi-omics information analysis.

resultsTo address the challenges of multi-omics research, our approach DeepMoIC presents a novel framework derived from deep Graph Convolutional Network (GCN). Leveraging autoencoder modules, DeepMoIC extracts compact representations from omics data and incorporates a patient similarity network through the similarity network fusion algorithm. To handle non-Euclidean data and explore high-order omics information effectively, we design a Deep GCN module with two strategies: residual connection and identity mapping. With extracted higher-order representations, our approach consistently outperforms state-of-the-art models on a pan-cancer dataset and 3 cancer subtype datasets.

conclusionThe introduction of Deep GCN shows encouraging performance in terms of supervised multi-omics feature learning, offering promising insights for precision medicine in cancer research. DeepMoIC can potentially be an important tool in the field of cancer subtype classification because of its capacity to handle complex multi-omics data and produce reliable classification findings.

Indexed as

NeoplasmsAlgorithmsComputational BiologyDeep LearningGenomicsHumansMultiomicsNeural Networks, ComputerCancer subtype classificationDeep graph convolutional networkMulti-omicsSupervised learning

Identifiers

PMID39695368
PMCPMC11658304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.